Dion R A, Verhelst R, Goenen M, Rousseau M, Baele P, Ponlot R, Schoevaerdts J C, Chalant C H
Cardiovascular and Thoracic Surgery, Cliniques Universitaires St. Luc, Brussels, Belgium.
J Cardiovasc Surg (Torino). 1989 Jul-Aug;30(4):635-42.
In the hope of establishing the internal mammary artery (IMA) as a true but superior substitute for the saphenous vein (SV) we reviewed our initial experience in complex IMA grafting. The first 120 consecutive patients, having received at least one sequential IMA graft were analyzed. The length of the IMA pedicle was the only limitation imposed on its use. Technical artifices enhancing the versatility of the IMA are described. The significant peri-operative myocardial infarction rate was 3.3%. There was no cardiac operative mortality, and 1 late mortality (0.8%). Excellent functional results were illustrated by a 2.5% rate of residual angina and dyspnoea. Six months postoperative angiographic controls could be performed in 70% of the patients: all of the sequential mammary conduits were patent, as were 95% of the anastomoses. By contrast 87.2% of the concomitant venous anastomoses were still functioning. With the expanding utilization of the free graft, IMA is expected to become a true, better and all round substitute for the saphenous vein.
为了将乳内动脉(IMA)确立为大隐静脉(SV)真正且更优的替代物,我们回顾了我们在复杂IMA移植方面的初步经验。对连续接受至少一次序贯IMA移植的前120例患者进行了分析。IMA蒂的长度是其使用的唯一限制。描述了增强IMA通用性的技术技巧。围手术期心肌梗死的显著发生率为3.3%。无心脏手术死亡,1例晚期死亡(0.8%)。残余心绞痛和呼吸困难发生率为2.5%,显示出优异的功能结果。70%的患者术后6个月可进行血管造影对照:所有序贯乳腺血管均通畅,95%的吻合口也通畅。相比之下,同期静脉吻合口仍有87.2%在发挥功能。随着游离移植物使用的不断增加,IMA有望成为大隐静脉真正、更好且全面的替代物。